文献速递重症综合管理与镇静镇痛消化、代谢与肾脏急症

尿素/肌酐比值作为重症监护新兴生物标志物:范围综述与Meta分析

The urea-to-creatinine ratio as an emerging biomarker in critical care: a scoping review and meta-analysis.
PubMed 文献 · Crit Care · 2025-05-02
一句话结论入住ICU时尿素/肌酐比值(BUN/肌酐,mg/dL)≥20与院内死亡风险相关(RR 1.60,95%CI 1.27-2.00),但校正后未达统计学显著(aHR 1.29,95%CI 0.89-1.86)。

该范围综述遵循PRISMA-ScR指南,于2024年9月3日检索Embase、PubMed、ScienceDirect和Cochrane Library,从1450项研究中纳入47项,聚焦尿素/肌酐比值(UCR)与蛋白质分解代谢及持续性危重症(10项)、死亡率(16项)、膳食蛋白质干预(2项)及其他结局(19项,如谵妄、神经和心脏不良事件)的关系。UCR随时间与肌肉横截面积呈负相关,并与ICU住院时长相关。入住ICU时UCR(BUN/肌酐,mg/dL)≥20(相当于尿素/肌酐mmol/L约80)较<20者,院内死亡RR 1.60(95%CI 1.27-2.00),校正HR 1.29(95%CI 0.89-1.86)。作者认为UCR升高可能提示肌肉蛋白质分解代谢和向持续性危重症进展,入住ICU时高值可能与死亡率相关;脱水、消化道出血、肝肾功能障碍和肾脏替代治疗可能影响UCR,是评估分解代谢阶段的潜在陷阱;需按患者群体确定切点值。

要点

  • 入住ICU时UCR(BUN/肌酐,mg/dL)≥20较<20者院内死亡RR 1.60(95%CI 1.27-2.00),校正HR 1.29(95%CI 0.89-1.86),校正后未达统计学显著。
  • UCR随时间与肌肉横截面积呈负相关,并与ICU住院时长相关,可能有助于识别持续蛋白质分解代谢的患者。
  • ICU住院期间UCR升高可能提示外源性膳食蛋白质摄入过量,超出机体用于全身或肌肉蛋白质合成的能力。
  • 脱水、消化道出血、肝肾功能障碍和肾脏替代治疗可能影响UCR,是评估危重症分解代谢阶段的潜在陷阱。
  • 作者认为需按患者群体确定切点值以确保UCR在临床实践中的有效性和应用。

适用人群与场景

  • 成人重症患者(范围综述纳入标准:危重症成人且至少报告一个UCR值)。

诊断标准与关键阈值

  • 入住ICU时UCR(BUN/肌酐,mg/dL)≥20(相当于尿素/肌酐mmol/L约80)为高值组,<20为低值组。

研究设计与关键结果

  • 范围综述遵循PRISMA-ScR指南,2024年9月3日检索Embase、PubMed、ScienceDirect和Cochrane Library,从1450项研究中纳入47项。
  • 47项研究中,10项关注UCR与蛋白质分解代谢及持续性危重症,16项关注死亡率,2项关注膳食蛋白质干预,19项关注其他结局(如谵妄、神经和心脏不良事件)。
  • UCR随时间与肌肉横截面积呈负相关,并与ICU住院时长相关。
  • 入住ICU时UCR(BUN/肌酐,mg/dL)≥20较<20者,院内死亡RR 1.60(95%CI 1.27-2.00),校正HR 1.29(95%CI 0.89-1.86)。

证据类型、等级与局限

  • 证据类型:范围综述与Meta分析(对≥5项相同结局参数的研究进行Meta分析)。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为UCR升高可能提示肌肉蛋白质分解代谢和向持续性危重症进展,入住ICU时高值可能与死亡率相关。
  • 作者认为ICU住院期间UCR升高可能提示外源性膳食蛋白质摄入过量。
  • 作者指出脱水、消化道出血、肝肾功能障碍和肾脏替代治疗可能影响UCR,是评估危重症分解代谢阶段的潜在陷阱。
  • 作者认为需按患者群体确定切点值以确保UCR在临床实践中的有效性和应用。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: Severe protein catabolism is a major aspect of critical illness and leads to pronounced muscle wasting and, consequently, extended intensive care unit (ICU) stay and increased mortality. The urea-to-creatinine ratio (UCR) has emerged as a promising biomarker for assessing protein catabolism in critical illness, which is currently lacking. This review aims to elucidate the role of UCR in the context of critical illness.

METHODS: This scoping review adhered to the PRISMA Extension for Scoping Reviews guidelines. A comprehensive literature search was conducted on the 3rd of September 2024, across Embase, PubMed, ScienceDirect, and Cochrane Library to identify studies related to (1) critically ill adult patients and (2) reporting at least a single UCR value. A meta-analysis was conducted for ≥ 5 studies with identical outcome parameters.

RESULTS: Out of 1,450 studies retrieved, 47 were included in this review, focusing on UCR's relation to protein catabolism and persistent critical illness (10 studies), mortality (16 studies), dietary protein interventions (2 studies), and other outcomes (19 studies), such as delirium, and neurological and cardiac adverse events. UCR is inversely correlated to muscle cross-sectional area over time and associated to length of ICU stay, emphasising its potential role in identifying patients with ongoing protein catabolism. A UCR (BUN-to-creatinine in mg/dL) of ≥ 20 (equivalent to a urea-to-creatinine in mmol/L of approximately 80) upon ICU admission, in comparison with a value < 20, was associated with a relative risk of 1.60 (95% CI 1.27-2.00) and an adjusted hazard ratio of 1.29 (95% CI 0.89-1.86) for in-hospital mortality.

DISCUSSION: UCR elevations during critical illness potentially indicate muscle protein catabolism and the progression to persistent critical illness, and high levels at ICU admission could be associated with mortality. UCR increments during ICU stay may also indicate excessive exogenous dietary protein intake, overwhelming the body's ability to use it for whole-body or muscle protein synthesis. Dehydration, gastrointestinal bleeding, kidney and liver dysfunction, and renal replacement therapy may also influence UCR and are considered potential pitfalls when assessing catabolic phases of critical illness by UCR. Patient group-specific cut-off values are warranted to ensure its validity and application in clinical practice.

来源:Crit Care,查看原文。版权归原作者所有。

参考来源

  1. Paulus MC, Melchers M, van Es A, et al. The urea-to-creatinine ratio as an emerging biomarker in critical care: a scoping review and meta-analysis. Crit Care. 2025. PMID: 40317012. doi:10.1186/s13054-025-05396-6

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。